Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Sports Shoes of 2024: Upgrade Execution and Solace - 2Vote in favor of the pasta that makes good dieting pleasant!
- 3NASA Artemis II tracker: Crew less than 60,000 miles from moon ahead of Monday flyby
- 4Australian State Triggers Emergency Powers Amid Fuel Crisis
- 5Can scientists detect life without knowing what it looks like? Research using machine learning offers a new way
- Spain’s Picos de Europa: What to see and do in ‘the world’s most beautiful place’
- Figure out How to Improve Your Stream Voyage with Remarkable Trips and Exercises
- Warnings rise for U.S. as severe flu strain causes outbreaks in Canada, U.K.
- Why haven’t humans been back to the moon in over 50 years?
- Bowen Yang is reportedly leaving 'Saturday Night Live' after this week's episode
- Ghassan Al-Duhaini to replace Abu Shabab as Popular Forces leader in Gaza
- Bahrain cracks down on dissent as war grinds on
- Japan deploys the military to counter a surge in bear attacks
- 5 Most Expected Film Delivery
